8-K: Research Solutions Q2 FY26: ARR Up 14%, Net Income Rebounds

Research Solutions, Inc. reported strong fiscal second quarter 2026 results, driven by a 14% increase in Annual Recurring Revenue and a significant return to net income.

Summary

• Annual Recurring Revenue (ARR) increased 14% year-over-year to $21.8 million, comprising $15.3 million in B2B ARR and $6.4 million in B2C ARR.
• The company achieved net income of $547,000, or $0.02 per diluted share, a substantial improvement from a net loss of $2.0 million, or ($0.07) per share, in the prior-year quarter.
• Adjusted EBITDA grew 36% year-over-year to $1.3 million, with trailing twelve-month Adjusted EBITDA reaching $5.8 million, representing 11.8% of revenue.
• Platform revenue increased 14% to $5.2 million, now accounting for 44% of total revenue, up from 39% in the prior-year quarter.
• Total revenue slightly decreased by 1.0% to $11.8 million, as strong B2B platform growth did not fully offset a decline in transactions revenue.
• Gross profit rose 6% to $6.2 million, with total gross margin improving 350 basis points to 52.4%.
• Operating expenses decreased 5.1% to $5.4 million, primarily due to reduced general and administrative and stock-based compensation expenses.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, highlighted by the significant return to net income, robust ARR growth, and improved profitability metrics, despite a slight dip in overall revenue due to transaction segment softness.

Positives

• Annual Recurring Revenue (ARR) increased 14% to $21.8 million.
• Achieved net income of $547,000 ($0.02 per diluted share) compared to a net loss of $2.0 million in the prior year.
• Adjusted EBITDA increased 36% to $1.3 million.
• Trailing twelve-month Adjusted EBITDA reached $5.8 million, or 11.8% of revenue.
• Net B2B ARR growth of $560,000 represents the best organic second quarter performance in company history.
• Forty-seven net new deployments in the quarter, reflecting sustained momentum in new B2B customer acquisition.
• Gross profit increased 6% to $6.2 million.
• Total gross margin improved 350 basis points to 52.4%.
• Platform revenue grew 14% to $5.2 million, increasing its share of total revenue to 44%.
• Average sales price for the Platform increased more than six percent year-over-year due to larger deals and increased adoption of SaaS and AI solutions.
• Operating expenses decreased 5.1% to $5.4 million, driven by reduced general and administrative and stock-based compensation expenses.
• Income from operations increased significantly by 696.3% to $739,351.
• Net cash provided by operating activities for the six months ended December 31, 2025, increased to $2,491,176 from $1,871,493 in the prior year.
• Cash and cash equivalents at period end increased to $12,262,780 from $7,701,155 in the prior year.
• Total stockholders' equity increased to $17,228,599 from $13,928,157 over six months.

Negatives

• Total revenue slightly decreased by 1.0% to $11.8 million, primarily due to softness in transactions revenue.
• Transaction revenue declined 10.2% to $6.6 million, impacted by a known customer churn and significant volume declines from a few larger customers.
• Transaction active customer count decreased to 1,321 from 1,384 in the prior-year quarter.
• B2C ARR saw a decrease of $93,781 in incremental ARR for the quarter, and a decrease of $279,940 for the six months ended December 31, 2025.
• Net cash used in financing activities significantly increased to $(2,436,443) for the six months ended December 31, 2025, from $(267,838) in the prior year, largely due to contingent acquisition consideration payments.

Risks

• Forward-looking statements are subject to a number of risks, uncertainties, and assumptions that are difficult to predict, estimate, or verify.
• Actual results may differ materially and adversely from those expressed in any forward-looking statements.
• Risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission.

Future Outlook

Management expects enhanced product offerings, additional customers, and continued prospects for growth, with a long-term focus on driving shareholder value. The company plans to reinvest strong operating cash flow and Adjusted EBITDA into sales and marketing to accelerate growth.

Management Comments

• "Our second quarter results reflect strong growth within our B2B Platforms business through forty-seven net new deployments in the quarter and Platforms continues to represent a larger portion of our total revenue mix."
• "In addition, the average sales price for our Platform increased more than six percent year-over-year as we signed larger deals and as existing customers adopt more of our SaaS and AI solutions."
• "Our business continues to generate strong operating cash flow and Adjusted EBITDA, allowing us to reinvest in sales and marketing to accelerate growth while maintaining financial flexibility."
• "We continue to manage the business with a long-term focus to drive value for our shareholders."

Industry Context

StockSavvy.ai notes that Research Solutions operates in the growing market of AI-powered research workflow platforms, a sector seeing increased demand for efficiency and access to scientific, technical, and medical (STM) content. The company's focus on B2B SaaS and AI solutions aligns with broader industry trends towards digital transformation and automation in research, positioning it to capitalize on the ongoing shift from traditional content access methods to integrated, intelligent platforms.

Stakeholder Impact

• Shareholders: Positive impact due to return to net income, strong ARR growth, improved Adjusted EBITDA, and management's long-term focus on driving shareholder value.
• Customers (B2B Platform): Positive impact from continued strong B2B customer acquisition, increased average sales price, and adoption of SaaS and AI solutions, suggesting enhanced value.
• Customers (Transactions): Negative impact due to decline in transaction revenue and active customer count, indicating potential dissatisfaction or shift in usage patterns for some customers.

Next Steps

• Host a conference call on February 12, 2026, at 5:00 p.m. ET to discuss results.
• Continue to reinvest in sales and marketing to accelerate growth.
• Manage the business with a long-term focus to drive value for shareholders.
• Enhance product offerings and acquire additional customers.

Key Dates

Recommendation

The company's significant turnaround from a net loss to a net income, coupled with robust 14% ARR growth and a 36% increase in Adjusted EBITDA, signals strong operational improvements and a healthy underlying subscription business. Despite a minor dip in total revenue due to transaction segment softness, the shift towards higher-margin platform revenue and increased average sales price are highly favorable trends. The strong cash flow generation and management's commitment to reinvestment for growth further bolster the positive outlook, making it an attractive investment.

Keywords

Research Solutions, RSSS, Financial results, Earnings report, Q2 2026, Annual Recurring Revenue, ARR, Net income, Adjusted EBITDA, Platform revenue, Transaction revenue, B2B SaaS, AI-powered research, Scientific, Technical, Medical content, Research workflow